- Celiac Disease Research: Associated Diseases and Disorders
- Refractory Celiac Disease & Collagenous Sprue
- Origin and Immunophenotype of Aberrant IEL in Patients with Refractory Celiac Disease Type II
Origin and Immunophenotype of Aberrant IEL in Patients with Refractory Celiac Disease Type II
Jefferson Adams is a freelance writer living in San Francisco. His poems, essays and photographs have appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate among others.
He is a member of both the National Writers Union, the International Federation of Journalists, and covers San Francisco Health News for Examiner.com.View all articles by Jefferson Adams
Celiac.com 04/23/2012 - Aberrant intra-epithelial lymphocytes (IELs) are one of the major features of refractory celiac disease type II RCDII. They are categorized as pre-malignant cells, which can give rise to aggressive enteropathy-associated T cell lymphoma (EATL).
A medical research team recently studied the origin and immuno-phenotype of aberrant IEL in RCDII patients. The research team included G.J. Tack, R.L. van Wanrooij, A.W. Langerak, J.M. Tjon, B.M. von Blomberg, D.A. Heideman, J. van Bergen, F. Koning, G. Bouma, C.J. Mulder, and M.W Schreurs. They are affiliated with the Gastroenterology and Hepatology, VU University Medical Center, The Netherlands.
They also conducted phenotypical analysis on IELs isolated from biopsies taken from RCDII patients.
They found that aberrant IELs showed an increased expression of granzyme B, along with a reduced expression of PCNA. Biopsies of RCDII patients showed heterogenic TCR rearrangements in the aberrant IEL cells. The researchers suggest that this is likely due to a variation in maturity. Similarly, RCDII cell lines showed a heterogenic TCR rearrangement pattern.
From their data, the team concludes that aberrant IELs originate from deranged immature T lymphocytes and show clear differentiation to a cytotoxic phenotype.
Among RCDII patients, aberrant IELs showed different stages of maturity, and only the patients who had the most mature aberrant IEL cells developed an EATL.
As always, Celiac.com welcomes your comments (see below).
- Refractory Celiac Disease and EATL Patients Show Severe Malnutrition and Malabsorption at Diagnosis
- Persistently High Antibodies Reveal Non-responsive Celiac Disease
- Refractory Celiac Disease in a Country with High Celiac Rates
- Refractory Celiac Disease: Unlocking the Origin of Aberrant Lymphocytes
- Researchers Try to Identify Origins of Abnormal Cells in Refractory Celiac Disease Type II
- Cladribine Treatment Promising for Type II Refractory Celiac Disease
- Small Intestinal Release Mesalamine Safe and Effective Treatment for Refractory Celiac Disease Type I
- Continual Assessment of Intraepithelial Lymphocyte Immunophenotype and Clonality is Superior to Snapshot Analysis in Monitoring Refractory Celiac Disease
- Refractory Celiac Disease